Individualization of dose and fractionation of radiotherapy for head and neck cancers

被引：0
作者：
Blanchard, P. [1 ,2 ,3 ]
Biau, J. [4 ,5 ,6 ]
Castelli, J. [7 ,8 ,9 ]
Tao, Y. [1 ]
Graff, P. [10 ]
Nguyen, F. [1 ]
机构：
[1] Gustave Roussy, Dept Radiotherapie Oncol, Canc Campus,114 Rue Edouard Vaillant, F-94800 Villejuif, France
[2] CESP, INSERM, U1018, F-94800 Villejuif, France
[3] Univ Paris Saclay, F-94800 Villejuif, France
[4] Ctr Jean Perrin, Dept Radiotherapie Oncol, F-63000 Clermont Ferrand, France
[5] Univ Clermont Auvergne, F-63000 Clermont Ferrand, France
[6] INSERM, Imagerie Mol & Strat Theranost U1240, F-63000 Clermont Ferrand, France
[7] Ctr Eugene Marquis, Dept Radiotherapie, F-35000 Rennes, France
[8] INSERM, LTSI U1099, F-35000 Rennes, France
[9] Univ Rennes 1, F-35000 Rennes, France
[10] IUCT Oncopole, Dept Radiotherapie, F-31000 Toulouse, France
来源：
CANCER RADIOTHERAPIE | 2019年 / 23卷 / 6-7期
关键词：
Head and neck cancer; Nasopharyngeal cancer; Chemotherapy; Epstein-Barr virus; Meta-analysis; Radiotherapy; Fractionation; SQUAMOUS-CELL CARCINOMA; LOCALLY ADVANCED HEAD; TARGET VOLUMES CTV; HUMAN-PAPILLOMAVIRUS; RANDOMIZED-TRIAL; CONVENTIONAL RADIOTHERAPY; OROPHARYNGEAL CANCER; RADIATION-THERAPY; QUALITY-ASSURANCE; DE-ESCALATION;
D O I：
10.1016/j.canrad.2019.07.131
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Head and neck cancers comprise a variety of tumours depending on the sub-site, for which target volumes and the prescribed doses need to be individualized according to each patient's history and presentation. This article aims at describing the main factors involved in decision-making regarding dose and volume, as well as ongoing research. Contouring and treatment guidelines, use of altered fractionation, major prognostic factors, the role of Human papillomavirus and of functional imaging will be presented and discussed. (C) 2019 Societe francaise de radiotherapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码：784 / 788
页数：5
相关论文
共 50 条
  • [1] Advances in radiotherapy of head and neck cancers
    Tao, Yungan
    Daly-Schveitzer, Nicolas
    Lusinchi, Antoine
    Bourhis, Jean
    CURRENT OPINION IN ONCOLOGY, 2010, 22 (03) : 194 - 199
  • [2] Dynamics-Adapted Radiotherapy Dose (DARD) for Head and Neck Cancer Radiotherapy Dose Personalization
    Zahid, Mohammad U.
    Mohamed, Abdallah S. R.
    Caudell, Jimmy J.
    Harrison, Louis B.
    Fuller, Clifton D.
    Moros, Eduardo G.
    Enderling, Heiko
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (11):
  • [3] Comparison of Conventional Fractionation and Accelerated Fractionation With Concomitant Boost for Radiotherapy of Non-metastatic Stage IV Head-and-Neck Cancer
    Narvaez, Carlos
    Schild, Steven E.
    Rades, Dirk
    IN VIVO, 2021, 35 (01): : 411 - 415
  • [4] Dose and volume de-escalation of radiotherapy in head and neck cancer
    Garcia-Anaya, M. J.
    Segado-Guillot, S.
    Cabrera-Rodriguez, J.
    Toledo-Serrano, M. D.
    Medina-Carmona, J. A.
    Gomez-Millan, J.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2023, 186
  • [5] Postoperative (chemo) radiation in patients with squamous cell cancers of the head and neck - clinical results from the cohort of the clinical cooperation group "Personalized Radiotherapy in Head and Neck Cancer"
    Maihoefer, Cornelius
    Schuettrumpf, Lars
    Macht, Corinna
    Pflugradt, Ulrike
    Hess, Julia
    Schneider, Ludmila
    Woischke, Christine
    Walch, Axel
    Baumeister, Philipp
    Kirchner, Thomas
    Zitzelsberger, Horst
    Belka, Claus
    Ganswindt, Ute
    RADIATION ONCOLOGY, 2018, 13
  • [6] Concurrent chemotherapy and radiotherapy for head and neck cancer
    Burri, Ryan J.
    Lee, Nancy Y.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (03) : 293 - 302
  • [7] Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis
    Lacas, Benjamin
    Bourhis, Jean
    Overgaard, Jens
    Zhang, Qiang
    Gregoire, Vincent
    Nankivell, Matthew
    Zackrisson, Bjorn
    Szutkowski, Zbigniew
    Suwinski, Rafal
    Poulsen, Michael
    O'Sullivan, Brian
    Corvo, Renzo
    Laskar, Sarbani Ghosh
    Fallai, Carlo
    Yamazaki, Hideya
    Dobrowsky, Werner
    Cho, Kwan Ho
    Garden, Adam S.
    Langendijk, Johannes A.
    Viegas, Celia Maria Pais
    Hay, John
    Lotayef, Mohamed
    Parmar, Mahesh K. B.
    Auperin, Anne
    van Herpen, Carla
    Maingon, Philippe
    Trotti, Andy M.
    Grau, Cai
    Pignon, Jean-Pierre
    Blanchard, Pierre
    LANCET ONCOLOGY, 2017, 18 (09) : 1221 - 1237
  • [8] Weekly cisplatin with radiotherapy for locally advanced head and neck squamous cell carcinoma
    Sautois, Brieuc
    Schroeder, Helene
    Martin, Marie
    Piret, Pascal
    Demez, Pierre
    Bouchain, Olivier
    Mutijima, Eugene
    Moreau, Pierre
    JOURNAL OF BUON, 2016, 21 (04): : 979 - 988
  • [9] Head and Neck Cancers
    Pfister, David G.
    Ang, Kie-Kian
    Brizel, David M.
    Burtness, Barbara A.
    Cmelak, Anthony J.
    Colevas, Dimitrios
    Dunphy, Frank
    Eisele, David W.
    Gilbert, Jill
    Gillison, Maura L.
    Haddad, Robert I.
    Haughey, Bruce H.
    Hicks, Wesley L., Jr.
    Hitchcock, Ying J.
    Kies, Merrill S.
    Lydiatt, William M.
    Maghami, Ellie
    Martins, Renato
    McCaffrey, Thomas
    Mittal, Bharat B.
    Pinto, Harlan A.
    Ridge, John A.
    Samant, Sandeep
    Sanguineti, Giuseppe
    Schuller, David E.
    Shah, Jatin P.
    Spencer, Sharon
    Trotti, Andy, III
    Weber, Randal S.
    Wolf, Gregory T.
    Worden, Frank
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2011, 9 (06): : 596 - 649
  • [10] Predictive modeling of hypoxic head and neck cancers during fractionated radiotherapy with gold nanoparticle radiosensitization
    Huynh, Myxuan
    Kempson, Ivan
    Bezak, Eva
    Phillips, Wendy
    MEDICAL PHYSICS, 2021, 48 (06) : 3120 - 3133
12345